Healthcare Services

Global Huntington’s Disease Market Forecast 2026–2035 Presenting Long-Term Industry Expansion Insights

April 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Forecasted Market Value Of The Huntington’s Disease Market Across 2026–2030?

The Huntington’s disease market has experienced significant expansion in recent years. It is projected to increase from $0.55 billion in 2025 to $0.64 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 17.9%. The market’s growth in previous periods can be attributed to the discovery of the htt gene mutation, the scarcity of curative treatments, a growing understanding of rare neurodegenerative diseases, a reliance on symptomatic therapies, and an uptick in diagnoses via genetic testing.

The Huntington’s disease market is anticipated to undergo substantial growth over the next few years. It is projected to reach $1.22 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 17.5%. This expansion during the forecast period is primarily driven by breakthroughs in gene therapy and RNA-based treatments, increasing investment in rare disease research, an expanding clinical pipeline for disease-modifying therapies, a heightened focus on early intervention strategies, and enhanced support from patient advocacy organizations. Key trends expected in the forecast period include a stronger emphasis on disease-modifying and gene silencing therapies, the wider adoption of genetic testing for prompt and accurate diagnosis, a rising commitment to multidisciplinary symptom management approaches, the expansion of clinical trials targeting neurodegenerative disorders, and the increasing implementation of patient-centric care models alongside home-based management.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=22008&type=smp

What Drivers Are Shaping The Future Growth Of The Huntington’s Disease Market?

The increasing incidence of neurological conditions is projected to boost the expansion of the huntington’s disease market in the future. These disorders are defined as medical conditions impacting the brain, spinal cord, and nerves, resulting in impairments related to movement, coordination, sensation, or cognition. Their rise can be linked to factors like an aging demographic, environmental contaminants, shifts in lifestyle, enhanced diagnostic methods, and genetic predispositions, facilitating the detection of a greater number of cases. Specifically, Huntington’s disease is a neurodegenerative condition stemming from a genetic mutation, characterized by worsening motor dysfunction, cognitive decline, and psychiatric symptoms over time. An example illustrates this trend: in March 2023, the Alzheimer’s Association, a US-based nonprofit voluntary health organization, reported approximately 6.7 million Americans aged 65 and older living with Alzheimer’s dementia. This figure is projected to surge to 13.8 million by 2060 without advancements to prevent, slow, or cure the illness. Consequently, the growing occurrence of neurological disorders is a significant driver for the expansion of the huntington’s disease market.

What Segmentation Levels Are Considered In The Huntington’s Disease Market?

The huntington’s disease market covered in this report is segmented –

1) By Treatment Type: Symptomatic Therapy, Disease-Modifying Therapy, Other Treatment Types

2) By Diagnosis: Magnetic Resonance Imaging (MRI), Genetic Testing

3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy

4) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users

Subsegments:

1) By Symptomatic Therapy: Antipsychotics, Antidepressants, Mood Stabilizers, Muscle Relaxants

2) By Disease-Modifying Therapy: Gene Silencing Therapies, Neuroprotective Agents

3) By Other Treatment Types: Physical Therapy, Occupational Therapy, Speech Therapy

Which Market Trends Are Creating New Opportunities In The Huntington’s Disease Market?

Companies active in the Huntington’s disease market are concentrating their efforts on creating novel treatments, including oral small molecule drugs, designed to manage symptoms and impede the advancement of the illness. These drugs are defined as low-molecular-weight compounds suitable for oral intake, engineered to engage with biological targets like proteins or enzymes to combat diseases. For example, in September 2024, the US-based pharmaceutical firm PTC Therapeutics Inc. obtained Fast Track designation from the U.S. Food and Drug Administration (USFDA) for its PTC518 program, which targets Huntington’s disease. This particular designation is granted to therapies that address considerable unmet medical needs, thereby emphasizing PTC518’s promise as a disease-modifying intervention for individuals affected by this genetic condition.

Which Leading Firms Are Contributing To The Growth Of The Huntington’s Disease Market?

Major companies operating in the huntington’s disease market are Novartis AG, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Apotex Inc, Ipsen S.A., Vertex Pharmaceuticals Incorporated, H. Lundbeck A/S, Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals PLC, Lupin Limited., Neurocrine Biosciences Inc., Alnylam Pharmaceuticals Inc, PTC Therapeutics Inc., Annexon Inc., Voyager Therapeutics Inc., Stealth BioTherapeutics Corp., Vaccinex Inc., SOM Biotech S.L., Alterity Therapeutics Limited, Medesis pharma SA.

Read the full huntington’s disease market report here:

https://www.thebusinessresearchcompany.com/report/huntingtons-disease-global-market-report

Which Geographic Regions Are Influencing Demand In The Huntington’s Disease Market?

North America was the largest region in the huntington’s disease market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the huntington’s disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Huntington’s Disease Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=22008&type=smp

Browse Through More Reports Similar to the Global Huntington’s Disease Market 2026, By The Business Research Company

Rare Neurological Disease Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/rare-neurological-disease-treatment-global-market-report

Progressive Ataxia And Weakness Disorders Global Market Report

https://www.thebusinessresearchcompany.com/report/progressive-ataxia-and-weakness-disorders-global-market-report

Alzheimers Drugs Global Market Report

https://www.thebusinessresearchcompany.com/report/alzheimers-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795